How to Starve Cancer

Product Information

The Metro Map is the key to starving the cancer. Once you’ve done that, killing it becomes much easier,” said McLelland. After intensive research, McLelland concluded that all of these drugs would starve the cancer from different angles: dipyridamole cut off cancer’s access to protein, metformin cut off access to glucose, and the statin cut off access to fat. Once the cancer cells were in their weakened state, the addition of etodolac could help finish them off.

In her book, McLelland provides all the information a cancer patient might need to point them in the right direction for developing a protocol to starve their cancer. That growth activity requires energy, and so cancer cells metabolize nutrients in different ways from the healthy cells around them. In an attempt to kill the tumor without killing the normally functioning cells, chemotherapy drugs target these pathways inside of cancer cells. This is notoriously difficult, expensive, and prone to toxic side effects that account for much of the suffering associated with the disease. McLelland underwent surgery to remove the tumor in her lung, and she endured six months of chemo (at a much lower dose than that recommended by her oncologist). But this time, she also employed a strategy to starve the cancer’s stem cells. After being given a terminal diagnosis with only a few weeks to live, Jane dug up research, some decades old, in her quest to survive. Rather than aiming to cure cancer, which in many cases is unachievable, Jane\x27s approach was to stop it growing. Remarkably her approach not only stopped it growing, it disappeared altogether. There are now clinics following her protocol, achieving remarkable successes. This book is a game\-changing new dawn in the treatment of cancer. For people currently struggling with a cancer diagnosis, McLelland has an important message: Never give up.

Working Together

I didn’t want to have to relive everything,” said McLelland, “but I knew I had information I had to pass on. It was a social responsibility to provide people with information they weren’t getting elsewhere.” But McLelland refused to go down without a fight. Taking matters into her own hands, she dug through medical journals, poring over long-forgotten research and overlooked evidence, looking for clues to overcoming her cancer. All of these drugs are cheap and off-patent, which is why they have largely been ignored by the pharmaceutical industry, despite research supporting their effectiveness against cancer,” said McLelland.

This strategy could be applied beyond rare sarcoma tumors because the metabolic defect is often present in other cancers, including certain types of breast, colon, lung, brain and bone tumors, the researchers said. The new study includes data showing similar anti-tumor responses in cell lines from these cancer types. Van Tine also pointed out that all of the drugs used in the study are either already approved by the U.S. Food and Drug Administration for other conditions or in ongoing clinical trials investigating cancer drugs. Just like the cervical cancer, Jane’s lung cancer was initially misdiagnosed (this time as a chest infection). But the benefit of having the improperly read X-ray from four months prior—along with the properly diagnosed X-ray—was the ability to see the rate at which the cancer was growing. Unable to make or obtain external arginine, the tumor cells’ fuel supply routes are forced inward. The cells must begin to metabolize their internal supply of arginine in a process called autophagy, or “self-eating.” In the case of sarcomas, this state slows or pauses cancer growth but does not kill the cell. During this period, tumor cells appear to be buying time to find yet another internal work-around.STARS! I'm in tears. I just finished chapter 19 of this book. I just love Jane! I love her. Her ❤️, her tenacity in the face of crazy levels of difficulty, and her desire to share!! According to doctors and cancer statistics, she should have lived only about 12 weeks after receiving her diagnosis of stage IV cancer.